Stay updated with breaking news from Per Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biophytis / Key word(s): MiscellaneousBiophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CESTBiophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program in sarcopenia,...
Biophytis / Key word(s): Annual ResultsBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives 07-Apr-2022 / 08:00 CET/CESTBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives Success of Nasdaq IPO in February 2021 €23.9M o...
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the...
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for...